Open Data

ES EN

Santhera Pharmaceuticals Holding AG : Santhera and ReveraGen Announce New 2 . 5 - year Treatment Data with Vamorolone in Duchenne Muscular Dystrophy

Source: finanznachrichten.de
Published on 2021-04-28

« SCVNews . com | Tuesday COVID - 19 Roundup : L . A . County Inching Closer to Yellow Tier ; SCV Totals 27 , 686 Cases
Santhera and ReveraGen Announce New 2 . 5 - year Treatment Data with Vamorolone in Duchenne Muscular Dystrophy  »